FADS2 and psoriasis: In the imiquimod (IMQ)‐induced psoriasis‐like mouse model, FADS2 expression in keratinocytes was significantly reduced in skin lesions and continued to decrease as the disease progressed (Figure 1I; Figure S1A, Supporting Information).